trial

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

NCTId NCT05890183
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 100 (estimated)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2028-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2023-05-23
Primary completion
2028-05-31
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Cognitive trainingAerobic Exercise ProgramModerated Online Social Therapy (MOST)Chorus Participatory Text Messaging ProgramHealthy Living Group (HLG)

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Keith H. Nuechterlein, PhDPrincipal Investigator

Sites

1 total
Los Angeles, United States

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2028-05-31
Status
RECRUITING
relationships
The graph out of here
drug
Cognitive training
drug
Aerobic Exercise Program
drug
Moderated Online Social Therapy (MOST)
drug
Chorus Participatory Text Messaging Program
drug
Healthy Living Group (HLG)
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Keith H. Nuechterlein, PhD
person